Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ORTHOPEDIATRICS CORP Director's Dealing 2020

Jun 29, 2020

32906_dirs_2020-06-29_59493b28-06cd-4def-9738-86a4412f046a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2020-06-25

Reporting Person: Throdahl Mark C (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-25 Common Stock A 30000 $44.08 Acquired 184946 Direct
2020-06-25 Common Stock S 13389 $42.88 Disposed 171557 Direct

Footnotes

F1: Includes restricted stock awards totaling 36,295 shares.

F2: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.